News

The company’s worldwide pharmaceutical sales grew 17% in the quarter, while US pharmaceutical sales increased 27%. This was driven by a 50% increase in Humira’s global sales to

First-half profit climbed 24% to 4.9 billion Swiss francs ($4.1 billion) on the back of strong sales of Herceptin, Avastin, and MabThera. On average, analysts had predicted net

This Phase I trial is planned to enroll up to 72 healthy adult volunteers and is primarily intended to evaluate the safety and tolerability of single ascending doses

The submission is based on the 24-week efficacy and safety results of two Phase III randomized, placebo-controlled studies, known as DUET-1 and DUET-2, which studied the use of

The companies plan to sell the insulin to biotechnology and pharmaceutical companies. Terms of the agreement have not been disclosed. Bioprocess scientists have increasingly used insulin to enhance

Abbott will take over marketing and distributing the product. The company acquired Kos Pharmaceuticals at the end of 2006. Merck entered into an agreement in 2002 with Kos

The condition is characterized by insufficient blood flow within the heart muscle, which gives rise to angina associated with coronary heart disease. Generx represents a new therapeutic class

Researchers found evidence that the drug could even contribute to swelling, heart failure and weight gain. The study examined pooled data from 18 past trials involving 8,000 patients.

MP-376 is a proprietary aerosolized formulation of the antibiotic levofloxacin that is being developed for the treatment of chronic lung infections due to pseudomonas aeruginosa in CF patients.